Evidence map›Paper›PMID 41049549›Full record

ArticleAdvances in ophthalmology practice and research

Shaping the future of myopia with artificial intelligence: Mapping trends and promising directions.

Zewei Zhang, Lingfeng Lv, Dongmei Chen, Yusheng Chen, Weijie Zhang, Fang Li, Jibo Zhou

Abstract read
In one paragraph

Article in Advances in ophthalmology practice and research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zewei ZhangDepartment of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lingfeng LvDepartment of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Dongmei ChenDepartment of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, China.
Yusheng ChenSchool of Medical Technology and Engineering, Fujian Medical University, China.
Weijie ZhangDepartment of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Fang LiDepartment of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jibo ZhouDepartment of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The worldwide increase in myopia and its associated complications has sparked a growing interest in the application of artificial intelligence (AI). This study aims to provide a comprehensive bibliometric analysis of the application of AI in myopia. Methods: Articles and review articles on AI in myopia were retrieved from the Web of Science Core Collection (WoSCC). VOSviewer and CiteSpace served as the core tools for bibliometric analysis. Results: Our study included a total of 305 relevant articles, with a steady increase in publications observed from 2010 to 2024. The People's Republic of China secured the top position among the most published countries and Capital Medical University and Sun Yat-sen University emerged as the most active institutions. Xu Xun and Zhou Xingtao contributed the most papers in this area. Translational Vision Science & Technology was the most prolific journal. Keywords analysis highlighted myopia management, orthokeratology and atropine, optical coherence tomography, refractive surgery, and myopia complications as key research areas. While notable advancements have been achieved in early screening, precise diagnosis, and progression prediction of myopia, research on intervention prognosis prediction and intervention decision-making remains inadequate. Conclusions: While AI has revolutionized myopia screening and diagnosis. further investigation is needed into clinical decision-making on interventions for myopia care. Balancing intervention costs, efficacy, and side effects is critical to advancing the development of AI in myopia in the future.

Indexed as

Artificial intelligenceBibliometric analysisCiteSpaceMyopiaVOSviewer

Identifiers

PMID41049549
PMCPMC12494824

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.